CLC number: R969.2
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2015-12-10
Cited: 1
Clicked: 4338
Hussam A. S. Murad.
@article{title="
author="Hussam A. S. Murad",
journal="Journal of Zhejiang University Science B",
volume="17",
number="1",
pages="43-53",
year="2016",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1500065"
}
%0 Journal Article
%T
%A Hussam A. S. Murad
%J Journal of Zhejiang University SCIENCE B
%V 17
%N 1
%P 43-53
%@ 1673-1581
%D 2016
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1500065
TY - JOUR
T1 -
A1 - Hussam A. S. Murad
J0 - Journal of Zhejiang University Science B
VL - 17
IS - 1
SP - 43
EP - 53
%@ 1673-1581
Y1 - 2016
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1500065
Abstract: Objective: Statins’ therapy in osteoporosis can aggravate muscle damage. This study was designed to assess which agent,
[1]Abdallah, H.M., Al-Abd, A.M., Asaad, G.F., et al., 2014. Isolation of anti-osteoporotic compounds from seeds of Sophora japonica. PLoS ONE, 9(6):e98559.
[2]Abdoli, N., Heidari, R., Azarmi, Y., et al., 2013. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J. Biochem. Mol. Toxicol., 27(6):287-294.
[3]Amelink, G.J., Koot, R.W., Erich, W.B., et al., 1990. Sex-linked variation in creatine kinase release, and its dependence on oestradiol, can be demonstrated in an in-vitro rat skeletal muscle preparation. Acta Physiol. Scand., 138(2):115-124.
[4]Bae, Y.J., Kim, M.H., 2010. Calcium and magnesium supplementation improves serum OPG/RANKL in calcium-deficient ovariectomized rats. Calcif. Tissue Int., 87(4):365-372.
[5]Bitto, A., Burnett, B.P., Polito, F., et al., 2009. Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br. J. Pharmacol., 156(8):1287-1295.
[6]Bookstaver, D.A., Burkhalter, N.A., Hatzigeorgiou, C., 2012. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am. J. Cardiol., 110(4):526-529.
[7]Bouzid, K., Bahlous, A., Kalaï, E., et al., 2010. C-telopeptides of type I collagen in postmenopausal women: an experience in a Tunisian clinical laboratory. Tunis. Med., 88(7):467-469.
[8]Brown, J.P., Albert, C., Nassar, B.A., et al., 2009. Bone turnover markers in the management of postmenopausal osteoporosis. Clin. Biochem., 42(10-11):929-942.
[9]Chang, B., Yang, J., Li, H., et al., 2011. Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats. Pharmazie, 66(7):535-537.
[10]Chirapapaisan, N., Uiprasertkul, M., Chuncharunee, A., 2012. The effect of coenzyme Q10 and curcumin on chronic methanol intoxication induced retinopathy in rats. J. Med. Assoc. Thai., 95(Suppl. 4):S76-S81.
[11]Colucci, S., Mori, G., Vaira, S., et al., 2005.
[12]Costa, R.A., Fernandes, M.P., de Souza-Pinto, N.C., et al., 2013. Protective effects of
[13]Cummings, S.R., Karpf, D.B., Harris, F., et al., 2002. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am. J. Med., 112(4):281-289.
[14]Endo, A., 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res., 33(11):1569-1582.
[15]Estai, M.A., Suhaimi, F., Soelaiman, I.N., et al., 2011. Bone histomorphometric study of young rats following oestrogen deficiency. Afr. J. Biotechnol., 10(56):12064-12070.
[16]Farhat, G.N., Cauley, J.A., 2008. The link between osteoporosis and cardiovascular disease. Clin. Cases Miner. Bone Metab., 5(1):19-34.
[17]Gradosova, I., Zivna, H., Palicka, V., et al., 2012. Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats. Eur. J. Pharmacol., 679(1-3):144-150.
[18]Gülçin, I., 2006. Antioxidant and antiradical activities of
[19]Høegh-Andersen, P., Tankó, L.B., Andersen, T.L., et al., 2004. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res. Ther., 6(2):R169-R180.
[20]Hooshmand, S., Balakrishnan, A., Clark, R.M., et al., 2008. Dietary
[21]Huber, C., Collishaw, S., Mosley, J.R., et al., 2007. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance. Calcif. Tissue Int., 81(2):139-144.
[22]Jun, D.W., Cho, W.K., Jun, J.H., et al., 2011. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction. Liver Int., 31(9):1315-1324.
[23]Karahan, S., Kincaid, S.A., Lauten, S.D., et al., 2002. In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study. Comp. Med., 52(2):143-151.
[24]Kaufmann, P., Török, M., Zahno, A., et al., 2006. Toxicity of statins on rat skeletal muscle mitochondria. Cell. Mol. Life Sci., 63(19-20):2415-2425.
[25]Kharode, Y.P., Sharp, M.C., Bodine, P.V., 2008. Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. In: Westendorf, J.J. (Ed.), Osteoporosis. Methods and Protocols, Humana Press, Vol. 455, p.111-124.
[26]Ko, Y.J., Wu, J.B., Ho, H.Y., et al., 2012. Antiosteoporotic activity of Davallia formosana. J. Ethnopharmacol., 139(2):558-565.
[27]Krakauer, T., 2008. Nuclear factor-κB: fine-tuning a central integrator of diverse biologic stimuli. Int. Rev. Immunol., 27(5):286-292.
[28]Kumaran, S., Subathra, M., Balu, M., et al., 2005. Supplementation of
[29]Kwak, H.B., Thalacker-Mercer, A., Anderson, E.J., et al., 2012. Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes. Free Radic. Biol. Med., 52(1):198-207.
[30]La Guardia, P.G., Alberici, L.C., Ravagnani, F.G., et al., 2013. Protection of rat skeletal muscle fibers by either
[31]Liu, S.Z., Yan, H., Hou, W.K., et al., 2009. Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. J. Zhejiang Univ.-Sci. B, 10(8):609-618.
[32]Luegmayr, E., Glantschnig, H., Wesolowski, G.A., et al., 2004. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ., 11:S108-S118.
[33]Majima, T., Komatsu, Y., Fukao, A., et al., 2007. Short term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr. J., 54(1):145-151.
[34]Mallinson, J.E., Constantin-Teodosiu, D., Glaves, P.D., et al., 2012. Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. J. Physiol., 590(24):6389-63402.
[35]Mazroa, S.A., Asker, S.A., 2010. Myotoxic effects of atorvastatin drug (Lipitor) on the skeletal muscles of adult male albino rats and the effect of
[36]Miyazaki, T., Matsunaga, T., Miyazaki, S., et al., 2004. Changes in receptor activator of nuclear factor-κB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. J. Cell. Biochem., 93(3):503-512.
[37]Moon, H.J., Ko, W.K., Jung, M.S., et al., 2013. Coenzyme Q10 regulates osteoclast and osteoblast differentiation. J. Food Sci., 78(5):H785-H891.
[38]Moustafa, A.M., Boshra, V., 2011. The possible role of
[39]Muthusami, S., Ramachandran, I., Muthusamy, B., et al., 2005. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin. Chim. Acta, 360(1-2):81-86.
[40]Nakahara, K., Yada, T., Kuriyama, M., et al., 1994. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors. Biochem. Biophys. Res. Commun., 202(3):1579-1585.
[41]Nakamura, Y., Naito, M., Hayashi, K., et al., 2008. Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats. J. Orthop. Surg. Res., 17(1):51-61. [doi:10.1186/1749-799X-3-51
[42]Ning, W.H., Zhao, K., 2013. Propionyl-
[43]Ott, S.M., 2001. Fractures after long-term alendronate therapy. J. Clin. Endocrinol. Metab., 86(4):1835-1836.
[44]Parfitt, A.M., 2002. High bone turnover is intrinsically harmful: two paths to a similar conclusion: the Parfitt view. J. Bone Miner. Res., 17(8):1558-1560.
[45]Patano, N., Mancini, L., Settanni, M.P., et al., 2008.
[46]Reddy Nagareddy, P., Lakshmana, M., 2005. Assessment of experimental osteoporosis using CT scanning, quantitative X-ray analysis and impact test in calcium deficient ovariectomized rats. J. Pharmacol. Toxicol., 52(3):350-355.
[47]Russo, E., Donato di Paola, E., Gareri, P., et al., 2013. Pharmacodynamic potentiation of antiepileptic drugs’ effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol. Res., 70(1):1-12.
[48]Schaars, C.F., Stalenhoef, A.F., 2008. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. Curr. Opin. Lipidol., 19(6):553-557.
[49]Seeman, E., Devogelaer, J.P., Lorenc, R., et al., 2008. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J. Bone Miner. Res., 23(3):433438.
[50]Seif, A.A., 2014. Nigella Sativa reverses osteoporosis in ovariectomized rats. BMC Complement. Altern. Med., 14(1):22.
[51]Siekmann, L., Bonora, R., Burtis, C.A., et al., 2002. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 7. Certification of four reference materials for the determination of enzymatic activity of γ-glutamyltransferase, lactate dehydrogenase, alanine aminotransferase and creatine kinase according to IFCC Reference Procedures at 37 °C. Clin. Chem. Lab. Med., 40(7):739-745.
[52]Sirvent, P., Mercier, J., Vassort, G., et al., 2005a. Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem. Biophys. Res. Commun., 329(3):1067-1075.
[53]Sirvent, P., Bordenave, S., Vermaelen, M., et al., 2005b. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem. Biophys. Res. Commun., 338(3):1426-1434.
[54]Sirvent, P., Mercier, J., Lacampagne, A., 2008. New insights into mechanisms of statin-associated myotoxicity. Curr. Opin. Pharmacol., 8(3):333-338.
[55]Sotiriadou, S., Kyparos, A., Mougios, V., et al., 2003. Estrogen effect on some enzymes in female rats after downhill running. Physiol. Res., 52(6):743-748.
[56]Staal, A., Frith, J.C., French, M.H., et al., 2003. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J. Bone Miner. Res., 18(1):88-96.
[57]Taha, D.A., de Moor, C.H., Barrett, D.A., et al., 2014. Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies. Transl. Res., 164(2):85-109.
[58]Tian, L., Dang, X.Q., Wang, C.S., et al., 2013. Effects of sodium ferulate on preventing steroid-induced femoral head osteonecrosis in rabbits. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 14(5):426-437.
[59]Tsartsalis, A.N., Dokos, C., Kaiafa, G.D., et al., 2012. Statins, bone formation and osteoporosis: hope or hype? Hormones (Athens), 11(2):126-139.
[60]Uyar, Y., Baytur, Y., Inceboz, U., et al., 2009. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Maturitas, 63(3):261-267.
[61]Venero, C.V., Thompson, P.D., 2009. Managing statin myopathy. Endocrinol. Metab. Clin. North Am., 38(1):121-136.
[62]Viereck, V., Gründker, C., Blaschke, S., et al., 2005. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. J. Cell. Biochem., 96(6):1244-1253.
[63]Virmani, A., Gaetani, F., Binienda, Z., 2005. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Ann. N. Y. Acad. Sci., 1053(1):183-191.
[64]Wang, J., Guo, T., 2013. Metabolic remodeling in chronic heart failure. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 14(8):688-695.
[65]Writing Group for the ISCD Position Development Conference, 2004. Position statement: executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference. J. Clin. Densitom., 7(1):7-12.
[66]Yao, W., Farmer, R., Cooper, R., et al., 2006. Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats. J. Musculoskelet. Neuronal. Interact., 6(3):277-283.
[67]Young, J.M., Molyneux, S.L., Reinheimer, A.M., et al., 2011. Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy. Atherosclerosis, 218(1): 188-193.
[68]Zhang, Y., Zheng, Y.X., Zhu, J.M., et al., 2015. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 16(7):611-621.
[69]Zlatohlavek, L., Vrablik, M., Grauova, B., et al., 2012. The effect of coenzyme Q10 in statin myopathy. Neuro Endocrinol. Lett., 33(Suppl. 2):98-101.
Open peer comments: Debate/Discuss/Question/Opinion
<1>